Malignant tumor (or suspected malignancy)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Prospective study (1); Patients diagnosed with a malignant tumor (or suspected malignancy) who explained to the person using the explanation consent document and obtained written consent Retrospective study (2); Patients diagnosed with a malignant tumor (or suspected malignancy) who have residual paraffin-embedded blocks collected in the past and can be immunohistochemically stained.
Exclusion criteria
Exclusion criteria: (1) Patients who are unable to obtain written consent from the individual to participate in the research (2) Patients who have opted out and have requested not to participate in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of rapid immunohistochemistry with a non-contact alternating-current electric-field mixing | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy of the combination of histology and molecular pathology by rapid immunohistochemistry with a non-contact alternating-current electric-field mixing | — |
Countries
Japan
Contacts
Akita University Hospital Thoracic Surgery